Viewing nowSamsung Moniflumate Tablet 350 mg
Morniflumate 350mg
Prescription medication
Samsung Pharmaceutical Co., Ltd.

MFDS item code 201503958 · Approved 2015.06.18 · Insurance code 642306640
Relief of pain and inflammation associated with osteoarticular, respiratory, and otorhinolaryngological disorders
This medication is effective in relieving pain and reducing inflammation. It is particularly used for inflammatory diseases such as laryngitis, tracheitis, and bronchitis, which are respiratory diseases. It also helps alleviate inflammation in ENT diseases such as sinusitis, otitis, tonsillitis, and pharyngitis. It is also utilized to improve pain and inflammation caused by orthopedic diseases. In summary, this medication is used to treat pain and inflammation associated with various respiratory and ENT diseases and orthopedic diseases.
Adults: The initial dose is 350 milligrams of morniflumate twice daily. Depending on the patient, the dose may be increased to a maximum of 700 milligrams twice daily. It is preferable to start with a low dose and increase it to the effective dose. Adjust the dose as appropriate according to the patient’s age and symptoms.
This medication may cause gastric bleeding in individuals who regularly consume more than three alcoholic beverages per day, so consultation with a doctor or pharmacist is essential. The medication can affect the cardiovascular system, increasing the risk of serious thrombotic events such as myocardial infarction or stroke, so patients with cardiovascular disease or risk factors should use caution. This medication may cause severe gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations, so elderly patients or those with a history of gastrointestinal diseases need to observe special precautions while taking it. This medication may induce allergic reactions, especially serious allergic symptoms such as anaphylaxis, so patients with a previous allergy to similar medications should not take it. This medication can mask inflammatory symptoms and may delay the diagnosis of infectious complications, so it should be used cautiously in suspected infections alongside appropriate antibiotics. Patients with serious conditions such as peptic ulcers, gastrointestinal bleeding, severe liver damage, renal impairment, heart failure, hypertension, or those with hypersensitivity to the drug components should not take this medication. In specific patient populations such as those with blood disorders, bleeding tendencies, liver damage, renal impairment, and the elderly, this medication should be used cautiously, and their condition should be closely monitored during administration. This medication may cause gastrointestinal symptoms such as nausea, vomiting, abdominal pain, diarrhea; in severe cases, gastrointestinal bleeding or ulcers may occur, so if abnormal symptoms appear, immediate consultation with medical personnel is necessary. This medication can rarely cause various side effects such as reduction in blood cell count, skin rashes, hepatitis, renal function deterioration, neurological and cardiovascular abnormalities, so if abnormal symptoms occur, it should be discontinued immediately and the doctor should be consulted. This medication should be used at the minimum effective dose and for the shortest duration possible; long-term administration requires regular blood tests and evaluation of liver and kidney function. This medication may interact with other non-steroidal anti-inflammatory drugs, anticoagulants, diuretics, lithium, methotrexate, so if taking other medications, it is essential to inform the healthcare provider. Pregnant or nursing women, children, and young children should not take this medication, and women who are capable of becoming pregnant should consider the risks and benefits carefully when using this medication. Elderly patients may experience adverse reactions more easily with this medication, so it is advisable to start with a lower dose and monitor their condition closely during treatment. This medication can cause ulcers by remaining in the esophagus, so it should be taken with a sufficient amount of water and should not be taken on an empty stomach or just before bedtime. In case of overdose, measures such as inducing vomiting, gastric lavage, and symptomatic treatment may be necessary, and symptoms such as renal failure, seizures, and hypotension may occur, so immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This can safely maintain the efficacy of the medication.
Cream-colored oval tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMorniflumate 350mg
Prescription medication
Samsung Pharmaceutical Co., Ltd.

Morniflumate 350mg
Prescription medication
Kolon Pharmaceutical Co., Ltd.
Morniflumate 350mg
Cream · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Morniflumate 350mg
Cream · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Morniflumate 350mg
Prescription medication
McNealty Pharmaceuticals Co., Ltd.

Morniflumate 350mg
Prescription medication
TerraGen Exotech Co., Ltd.

Morniflumate 350mg
Prescription medication
Allico Pharmaceutical Co., Ltd.

Morniflumate 350mg
Prescription medication
Hawon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.